Kozlov S A, Khyshiktuev B S, Logunov N A
Vestn Oftalmol. 2003 Mar-Apr;119(2):28-30.
The efficacy of 1% emoxipin solution (eye drops) in the nonproliferative stage of diabetic retinopathy was studied. The inhibition of lipid peroxidation and an enhancement of antioxidizing guard were observed both after the therapy by the above preparation and 3 months later. It was concluded that emoxipin was effective for leveling the biochemical violations in the "lipid peroxidation--antioxidants" system of lachrymal fluid in patients with the nonproliferative stage of diabetic retinopathy. The prescription of emoxipin eye drops can enhance the efficacy of therapy at the early stages of the disease.
研究了1%艾地苯醌溶液(滴眼液)在糖尿病视网膜病变非增殖期的疗效。在使用上述制剂治疗后及3个月后,均观察到脂质过氧化受到抑制且抗氧化保护作用增强。得出结论:艾地苯醌对糖尿病视网膜病变非增殖期患者泪液“脂质过氧化-抗氧化剂”系统中的生化异常具有调节作用。开具艾地苯醌滴眼液可提高疾病早期的治疗效果。